Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2023 / Jun / Clean Data… and other news
Glaucoma Research & Innovations

Clean Data… and other news

We take a quick tour of the most interesting glaucoma research

By Oscelle Boye 6/23/2023 3 min read

Share

Credit: Image sourced from Shutterstock.com

Picking parameters. A research group conducted a cross-sectional study to assess the accuracy of the performance of various optical coherence tomography (OCT) parameters in detecting glaucoma in highly myopic eyes (1). From this study, which included 132 patients, the researchers found that inferotemporal macular ganglion cell-inner plexiform layer thickness was the parameter that gave the highest diagnostic utility. They also noted that combining the temporal raphe sign with single OCT parameters, as was done in the University of North Carolina OCT index, may further enhance diagnostic performance in patients with high myopia.

Results translated. After developing a Moroccan Arabic dialect version of the Glaucoma Quality of Life-15 questionnaire, researchers examined the psychometric properties – including internal consistency, test-retest reliability and construct validity – of the translated tool (2). They found that the questionnaire, which was administered to 148 patients, took an average of just over three minutes and demonstrated adequate reliability and validity, positioning the tool as a valid and reliable tool for quality-of-life assessment within patients with glaucoma in Morocco.

Cannabis characterizations. What are the epidemiology and factors associated with cannabis use among open-angle glaucoma (OAG) patients? To answer this question, a University of California research group conducted a cross-sectional study of participants in the All of Us Research Program with OAG, finding that nearly half of this cohort were cannabis ever-users, with there being diversity within both ethnicity and socioeconomic characteristics including marital status, housing security and income and education levels (3). The findings may help identify patients who need additional outreach on unsupervised marijuana use.

Ratifying reports. Looking to provide direct clinical evidence to support the implication of heat shock protein (HSP)-specific T-cell responses in glaucoma pathogenesis by previous laboratory reports, a research team conducted a cross-sectional case-control study aiming to correlate SHP-specific T-cell levels with glaucoma severity in patients with primary open angle glaucoma (POAG) (4). They found that higher levels of HSP-specific Th1 cells are associated with thinner retinal nerve fiber layer thickness (RNFLT) in POAG patients and control subjects. This significant inverse relationship between RNFLT and the cell count of HSP-specific Th1 cells supports these T cells in glaucomatous neurodegeneration.

In Other News…
 

Differing damage. Differences in optic nerve head structure between OAG and acute angle-closure glaucoma (AACG) suggest alternate optic nerve damage mechanisms in the two diseases (5).

Non-causal code. DNA testing showed no non-synonymous mutations of EFEMP1 in juvenile open-glaucoma suggesting they are not a common cause of glaucoma (6).

No Added Ocular Surface Disease. Changing from preserved to preservative-free cyclosporine 0.1%  improves ocular surface health and IOP control (7).

Counting the cost. At six years post surgery, prophylactic laser peripheral iridotomy (IPL) is cost-effective in primary angle closure suspects with more accrued quality-adjusted life years (8).

Prayer pressure. Performing traditional Muslim prayer positions significantly increases IOP in both healthy and POAG patients, not immediately resolving in over a quarter of individuals (9).

References

  1. Y Jeong et al., JAMA Ophthalmol, [Online ahead of print] (2023). PMID: 37200038.
  2. M Maiouak et al., J Fr Ophthalmol, [Online ahead of print] (2023). PMID: 37225606.
  3. J Wu et al., Heliyon, 9, e15811 (2023). PMID: 37215923.
  4. C Saini et al., Opthalmol Sci, 3, 100310 (2023). PMID: 37197701.
  5. JH Kong et al., Sci Rep, 13, 7935 (2023). PMID: 37193817.
  6. AZ Tejan-Kamara et al., Ophthalmol Glaucoma, [Online ahead of print] (2023). PMID: 37224920.
  7. A Konstas et al., Eye (Lond), [Online ahead of print] (2023). PMID: 37221362.
  8. S Sood et al., Ophthalmol Glaucoma, [Online ahead of print] (2023). PMID: 37212626.
  9. N Dar et al., Eur J Ophthalmol, [Online ahead of print] (2023). PMID: 37218165.

About the Author(s)

Oscelle Boye

I have always been fascinated by stories. During my biomedical sciences degree, though I enjoyed wet lab sessions, I was truly in my element when sitting down to write up my results and find the stories within the data. Working at Texere gives me the opportunity to delve into a plethora of interesting stories, sharing them with a wide audience as I go.

More Articles by Oscelle Boye

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: